Office Opening

Mahall Ankara Turkiye office

PSI Expands Support for Global Clinical Trials With First Office in Türkiye

Mahall Ankara Turkiye officePSI CRO, 9 July 2024 – PSI CRO has announced the opening of its first office in Ankara, reflecting the company’s commitment to supporting pivotal clinical trials in Türkiye and around the globe.

Turkey’s clinical trial market is expected to grow over the next decade, providing high-quality pivotal data from diverse patient populations. The country’s proximity to key markets in Europe, Asia, and the Middle East makes it ideal for multinational trials, particularly in PSI’s core therapeutic focus areas of oncology, hematology-oncology, gastrointestinal diseases, infectious diseases, CNS, and other areas.

“The opening of our new office in Ankara is a testament to PSI’s ongoing growth in Turkey and our belief in the potential of the local clinical trial market,” said Mehmet Tunali, Clinical Operations Manager at PSI. “We are excited to provide a physical home that not only supports our business objectives but also promotes a positive and productive work environment.”

PSI’s new space is located in the heart of Ankara at Dumlupinar Bul. No: 274/7 Mahall Ankara. This prime location will help PSI’s sponsors unlock Türkiye’s untapped clinical trial potential by providing a space for collaboration and deepening relationships with local investigators, key opinion leaders, and other stakeholders. 

“This move aligns with our dedication to the passionate Turkish life sciences community, fostering stronger connections and driving growth,” said Genka Rizova, Country Manager at PSI.

With over 3,000 staff in 60 countries, PSI is the only CRO of its size still growing organically, offering its employees and customers stability and consistency uncommon among CROs. Explore PSI’s unique CRO offering here.

About PSI: PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors.

Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. www.psi-cro.com

For Media Inquiries:

Ashley Collins, Marketing Specialist

919-972-9572 | ashley.stufanocollins@psi-cro.com

 

 

 

 

 

PSI Expands Support for Global Clinical Trials With First Office in Türkiye Read More »

PSI Bulgaria office

Great Move: PSI CRO Expands to New Offices in Bulgaria

PSI CRO, 25 June 2024 – PSI CRO has moved its base of operations in Bulgaria to a new office in Sofia at 1 Atanas Dukov St. This new location allows PSI to continue expanding its presence in the region, combining local expertise with on-the-ground support for sponsors and sites.

The new office is located in one of Sofia’s most dynamic areas, highlighting the company’s commitment to staying agile and providing the highest level of quality for sponsors at the forefront of clinical research.

The PSI Bulgaria Team celebrated the opening of the new office with a tour and toast, surrounded by PSI colleagues from near and far in a welcoming environment. “The offices, the conference rooms, the collaboration areas, any place in the new office here is calm, beautiful, modern, airy, colorful, green, and cozy,” said Genka Rizova, Country Manager. “And that fills us with even more energy and drive to achieve even better performance across our clinical trials in Bulgaria. Our unchanging goal is predictable, reliable patient enrollment across our pivotal trials. Achieving it is never easy. Having a conveniently styled, beautiful, welcoming office space helps uphold the team’s spirit, collaboration and productivity. We are incredibly proud and excited about this new chapter!”

To learn more about the new Bulgaria office or PSI’s full-service CRO capabilities, connect with us here.

About PSI: PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors.

Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. www.psi-cro.com

For Media Inquiries:

Ashley Collins, Marketing Specialist

919-972-9572 |ashley.stufanocollins@psi-cro.com

 

 

 

Great Move: PSI CRO Expands to New Offices in Bulgaria Read More »

PSI CRO Broadens Global Reach by Further Expanding in Greece

PSI CRO, 11 June 2024 – PSI CRO has moved its base of operations in Greece to new offices in the heart of Athens. Located at Ermou 56, Athens 105 63, this new location expands PSI’s presence in the region while allowing the team to broaden site relationships and local expertise.

PSI opened its first Greek office in 2019 and remains committed to the growth and success of its team in the country. The company is dedicated to offering additional support and patient enrollment benefits with its expanded presence, maintaining its focus on on-time, on-budget and on-quality delivery of global pivotal trials across a variety of therapeutic areas.

We invite you to explore PSI’s unique CRO offering here.

About PSI: PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors.

Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. www.psi-cro.com

For Media Inquiries:

Ashley Collins, Marketing Specialist

919-972-9572 | ashley.stufanocollins@psi-cro.com

PSI CRO Broadens Global Reach by Further Expanding in Greece Read More »

PSI Shanghai Office Expands Global Support for Local Biotech & Pharma

PSI CRO, 28 May 2024 – PSI CRO is investing in its operational capabilities in the Asia-Pacific region with a focus on its Shanghai headquarters located at Units 02 and 06, 10th Floor (actual 9th floor), Ascendas Innovation Place, No. 686 Jiujiang Road, Huangpu District. The global full-service CRO relocated to the premises in 2022 and recently welcomed team members to the office for an official celebration.

PSI’s journey in Shanghai has been one of remarkable growth. From its beginnings in the WeWork Tengfei Building in People Square, PSI has quickly expanded its operations. At the end of 2020, the company moved to the 17th floor of the ZhongHai Building, marking another milestone in its growth trajectory.

PSI’s new office is strategically located in the heart of one of Shanghai’s traditional business districts, offering easy access to the metro station, airports, and high-speed train station. This prime location is a testament to PSI’s ongoing commitment to combining local support with global expertise for sponsors of pivotal Phase 2 and 3 trials.  

“The philosopher Lao Tzu said a journey of a thousand miles begins with a single step,” said Lisa Lu, PSI’s Country Manager, China. “At PSI, we are committed to being a trusted companion for our sponsors throughout the challenges of their clinical development journey. With this new move, we have taken another step forward in supporting the exciting future of biotech in China.”  

To learn more about the new Shanghai office or PSI’s full-service CRO capabilities, connect with us here.

About PSI: PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors.

Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. www.psi-cro.com

For Media Inquiries:

Ashley Collins, Marketing Specialist

919-972-9572 | ashley.stufanocollins@psi-cro.com

PSI Shanghai Office Expands Global Support for Local Biotech & Pharma Read More »

PSI CRO Continues Asia-Pacific Growth, Expands into New Office in Bangkok 

PSI CRO, 7 May 2024PSI CRO is continuing to expand its clinical research operations in the Asia-Pacific region with the opening of a new office in Bangkok, Thailand, at Park Silom, Unit 1407-1408, 1 Convent Road, Silom Bang Rak. The new Thailand location will add to PSI’s expansion in the region, further supporting the on-time delivery of clinical trials through local relationships and broadened operational capabilities. 

In Asia, PSI is already fully operational with a long-standing presence in South Korea, China, Hong-Kong, Taiwan, Singapore, Australia and New Zealand.  Barrie Koh, PSI Head of Asia Pacific, said, “Operational Expansion to Thailand marks a significant milestone for us, reinforcing our continued growth across Asia Pacific. The strategic location of our new office underscores our commitment to serving our clients with excellence, achieving reliable and predictable patient enrollment across the region. Every Patient Counts has been our mantra across PSI globally; here in Thailand it resonates with a great deal of significance and meaning. We are excited to add another high-enrolling country to PSI’s portfolio.” 

The new office is located in the heart of the Silom Bang Rak business district. It offers outstanding connectivity with its excellent transportation options, ensuring convenient access for employees. Additionally, the office space can accommodate a growing team of both operational and clinical local staff, allowing PSI teams to maintain a strong local presence and relationships with the clinical sites in the region.  

With a uniquely modern look and feel, the atmosphere of PSI’s Bangkok office is a testament to the distinctive dedication and partnership that PSI provides for employees and clinical trial sponsors alike. The team celebrated the official opening on April 4 with a ribbon-cutting ceremony and blessing performed by Buddhist monks. 

“Our team is dedicated to delivering exceptional service and solutions, and we are confident that our presence at Park Silom will enable PSI to better meet the evolving needs of our clients,” says Koh. “We extend our gratitude to our employees, sites, and clients for their continued support!” 

About PSI: PSI CRO is a privately-owned, full-service clinical research organization (CRO) operating globally. PSI’s global reach supports clinical trials across multiple countries and continents and specializes in the planning and execution of global pivotal registration clinical trials. With an exceptionally high repeat and referral business rate combined with minimal staff turnover, PSI is committed to being the best CRO in the world as measured by its employees, customers, investigators, and vendors. 

Global headquarters are located in Switzerland at 113a Baarerstrasse, Zug 6300. www.psi-cro.com 

For Media Inquiries: 

Ashley Collins, Marketing Specialist 919-972-9572 |ashley.stufanocollins@psi-cro.com 

 

PSI CRO Continues Asia-Pacific Growth, Expands into New Office in Bangkok  Read More »